Superoxide dismutase gene (SOD1, SOD2, and SOD3) polymorphisms and antituberculosis drug-induced hepatitis

Allergy, Asthma and Immunology Research

Volumn 7, Issue 1, 2014, Pages 88-91

  Kim, Sang Hoon ^a   Kim, Sang Heon ^b   Lee, Jae Hyoung ^a   Lee, Byoung Hoon ^a   Yoon, Ho Joo ^b   Shin, Dong Ho ^b   Park, Sung Soo ^b   Jang, Suk Bin ^c   Park, Jae Seuk ^c   Jee, Young Koo ^c  

^a Eulji University School of Medicine   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Dankook University College of Medicine   (South Korea)

Author keywords

Antituberculosis drugs; Hepatitis; Polymorphism; Superoxide dismutase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; TUBERCULOSTATIC AGENT;

ADULT; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; TOXIC HEPATITIS;

EID: 84919354986     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2015.7.1.88     Document Type: Article

References (16)

1. American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1-77.
2. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174:935-52.
3. Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology 2010;52:748-61.
4. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004;38 Suppl 2:S44-8.
5. Huang YS. Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury. Expert Opin Drug Metab Toxicol 2007;3:1-8.
6. Huang YS, Su WJ, Huang YH, Chen CY, Chang FY, Lin HC, et al. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 2007; 47:128-34.
7. Kim SH, Kim SH, Yoon HJ, Shin DH, Park SS, Kim YS, et al. GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans. Tuberculosis (Edinb) 2010;90:39-43.
8. Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009;47:344-56.
9. Lucena MI, García-Martín E, Andrade RJ, Martínez C, Stephens C, Ruiz JD, et al. Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology 2010;52:303-12.
10. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. Geneva: World Health Organization; 2010.
11. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167: 603-62.
12. Kim SH, Kim SH, Bahn JW, Kim YK, Chang YS, Shin ES, et al. Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. Pharmacogenomics 2009;10:1767-79.
13. Lei XG, Zhu JH, McClung JP, Aregullin M, Roneker CA. Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem J 2006;399:455-61.
14. Liu YM, Li XD, Guo X, Liu B, Lin AH, Rao SQ. Association between polymorphisms in SOD1 and noise-induced hearing loss in Chinese workers. Acta Otolaryngol 2010;130:477-86.
15. Kase BA, Northrup H, Morrison AC, Davidson CM, Goiffon AM, Fletcher JM, et al. Association of copper-zinc superoxide dismutase (SOD1) and manganese superoxide dismutase (SOD2) genes with nonsyndromic myelomeningocele. Birth Defects Res A Clin Mol Teratol 2012;94:762-9.
16. Andrade RJ, Agúndez JA, Lucena MI, Martínez C, Cueto R, García-Martín E. Pharmacogenomics in drug induced liver injury. Curr Drug Metab 2009;10:956-70.